A gift to the Department of Surgery helps our physicians and scientists find new treatments and cures for serious diseases.
Matthew Y.C. Lin, M.D. is a gastrointestinal surgeon and Assistant Professor of Surgery at UCSF. Dr. Lin is board-certified by the American Board of Surgery.
Dr. Lin received his M.D. from UCLA School of Medicine followed by a general surgery residency at Harbor-UCLA Medical Center. In 2011-2012, Dr. Lin was the UCSF fellow in minimally invasive and bariatric surgery, a position funded by the Foundation for Surgical Fellowships.
In June, 2012, Dr. Lin presented the results of an study to the 29th Annual Meeting of the American Society for Metabolic & Bariatric Surgery (ASMBS) suggesting sleeve gastrectomy may be performed safely in carefully selected morbidly obese patients with impending organ failure and the significant weight loss they achieve may make them more suitable candidates for transplantation. The study was conducted by UCSF bariatric and transplant faculty. It was the largest such study of its kind to date. The story was also reported by ABC News.
Dr. Lin has published numerous peer-reviewed articles and is a member of the American Medical Association, American College of Surgeons, Society of American Gastrointestinal and Endoscopic Surgeons and American Society for Metabolic and Bariatric Surgery.
"Bariatric surgery has been widely accepted in the medical field, but now we're trying to apply it to specific patient groups," said Matthew Y.C. Lin, M.D., a gastrointestinal surgeon, a former surgical fellow*, and now an Assistant Professor of Surgery at UCSF. In a pilot study of 26 morbidly obese patients waiting for a kidney or liver transplant, Dr. Lin and colleagues in the UCSF Bariatric Surgery Program found laproscopic sleeve gastrectomy, a procedure that removes most of the stomach and reshapes it into a small tube or sleeve, significantly improved the chances of undergoing successful organ transplantation. "The reason why physicians are skittish about bariatric surgery for organ transplant is that these patients have more medical comorbities," said Lin, who is the lead author of the study. "But our study shows that it is safe to proceed."
* Fellowship in Minimally Invasive Surgery generously underwritten by Foundation for Surgical Fellowships.